Element Solutions Inc current report, 01 October 2014

Business Context and Reporting Period

This Form 8-K Current Report, dated October 1, 2014, is filed by Platform Specialty Products Corporation (formerly Element Solutions Inc). The report details the completion of a strategic acquisition and a concurrent amendment to the company's credit facilities to finance the transaction.

Key Financial Metrics and Capital Structure

  • Acquisition Price: Approximately €300 million for Percival S.A. (Agriphar business), consisting of €285 million in cash and 711,551 shares of Platform common stock.
  • New Debt Issuance: $300 million in new U.S. Dollar term loans (New USD Term Loans).
  • Total Senior Secured Credit Facility:
    • U.S. Dollar term loans: $1,055 million aggregate principal.
    • U.S. Dollar revolving credit facility: $25 million.
    • Multi-currency revolving credit facility: $25 million.
  • Debt Maturity: June 7, 2020.
  • Interest Rate: Eurocurrency Rate plus Applicable Rate or Base Rate plus Applicable Rate.
  • Financial Covenant: If revolving borrowings exceed $12.5 million, the company must maintain a ratio of 6.5 to 1.0 of (consolidated indebtedness secured by a first lien minus unrestricted cash) to consolidated EBITDA.

Material Changes

The primary material change is the expansion of the company's debt load by $300 million to fund the acquisition of Percival S.A., a European crop protection group. This transaction establishes a new agrochemical segment for Platform. The credit agreement was amended to increase the tranche B term loans from $755 million to $1,055 million and to adjust amortization schedules accordingly.

Outlook, Risks, and Contingencies

Management Commentary: The acquisition of Percival (Agriphar) is expected to provide leading product development, registration, and distribution capabilities in Europe, including in-house formulation and packaging. The business will be integrated into Platform's new agrochemical segment.

Risks and Covenants: The credit agreement includes customary covenants limiting additional indebtedness, dividends, capital expenditures, and restricted payments. Events of default include non-payment, covenant violations, bankruptcy, and change of control. Borrowings are subject to mandatory prepayment from proceeds of permitted asset dispositions.

Unusual Items: The filing notes that the financial statements and exhibits are incorporated by reference; specific revenue or profit impacts from the acquisition are not quantified in this report.

Investor Verification Checklist

  • Verify the exact exchange rate used to convert the €300 million purchase price to U.S. dollars for financial statement impact.
  • Review the full text of the Incremental Amendment (Exhibit 10.1) for specific details on the "Applicable Rate" and fee structures.
  • Confirm the pro forma impact of the €285 million cash outflow on the company's liquidity and unrestricted cash balances.
  • Assess the integration timeline and expected synergies for the new agrochemical segment as detailed in the press release (Exhibit 99.1).
  • Monitor compliance with the 6.5 to 1.0 leverage ratio covenant, particularly given the increased debt load.